Physician profile
Sami Tannouri
NPI 1942567656
$12,369.33
in general payments reported to CMS, 2019-2025
14 companies · $1,266 in 2025
The $1,266 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $69.32 · 2021: $264 · 2022: $2,589 · 2023: $6,422 · 2024: $1,203 · 2025: $1,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,706 · Education: $2,500 · Food and Beverage: $2,049 · Honoraria: $1,620 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,706.22 |
| Education | $2,500.00 |
| Food and Beverage | $2,048.92 |
| Honoraria | $1,620.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,179.70 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $3,990.93 | 2020-2025 | Phasix Mesh, Avitene Ultrafoam, Arista |
| Asensus Surgical, INC. | $542.55 | 2019 | |
| W. L. Gore & Associates, INC. | $491.82 | 2023 | Gore Bio-A Tissue Reinforcement |
| Stryker Corporation | $405.71 | 2023 | Spy-Phi System |
| Becton, Dickinson and Company | $150.96 | 2024 | Phasix Mesh |
| Acera Surgical, INC. | $149.22 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $129.16 | 2024 | Spyglass Discover |
| Conmed Corporation | $94.98 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.97 | 2023-2024 | Gattex |
| Integra Lifesciences Corporation | $57.71 | 2020 | |
| Ethicon US, LLC | $52.09 | 2019-2025 | Harmonic |
| Baxter Healthcare | $50.43 | 2024-2025 | Floseal, Tisseel, Seprafilm |
| Smith+Nephew, INC. | $13.10 | 2023 | Oasis Micro, Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Tannouri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.